ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TDOC vs WGS // EV/EBITDA & P/E VALUATION

Teladoc Health Inc. (NYSE) VS. GeneDx Holdings Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: TDOC 2 — WGS 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDOC VS. WGS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TDOC WGS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 69.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -17.00% -4.10% -12.90 WGS /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield 18.00% 0.67% +17.33 TDOC /fcf-yield <GO>
Operating Margin -10.40% -3.10% -7.30 WGS /operating-margins <GO>
Net Profit Margin -7.90% -4.90% -3.00 WGS /net-margins <GO>
Revenue Growth (YoY) -1.50% 40.00% -41.50 WGS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.45 3.32 -2.87 WGS /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 WGS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 79.0 50.8 +28.20 TDOC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.08 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 32.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.59B $2.12B -$531.9M WGS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TDOC REV WGS REV TDOC GROSS % WGS GROSS % TDOC FCF WGS FCF
FY 2025 $2.53B $427.5M — 69.7% $285.5M $14.3M
FY 2024 $2.57B $305.4M — 63.6% $282.9M -$34.0M
FY 2023 $2.60B $202.6M — — $232.9M -$180.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDOC // BETA 1.08
WGS // BETA —